Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Health

AstraZeneca To Seek US Authorization For COVID-19 Vaccine This Month Or Early Next - Sources

The number of COVID-19 cases among those who got the vaccine versus infections in participants who received a placebo will show how effective the AstraZeneca shot was at preventing illness in those age 18 and over.

Read More

Geared Up To Support Govt In COVID-19 Vaccination Drive: Apollo Hospitals

A robust vaccination program is the need of the hour, and Apollo is glad for this opportunity to support and boost the government's efforts in ensuring that no eligible person is left out of the COVID-19 vaccine programme

Read More

Activists, Drug Groups In Waiver War Over COVID-19 Shot Patents

MSF has said countries could immediately scale up production, speeding deliveries to poorer nations that just now, via the COVAX vaccine-sharing scheme led by the GAVI vaccines alliance, are getting shots after wealthier nations were first in line.

Read More

Pfizer Wants To Make Vaccine In India If Faster Clearance, Export Freedom Assured

The Serum Institute of India, the world's largest vaccine maker, is already bulk-manufacturing the Oxford University/AstraZeneca product and plans to start producing the Novavax Inc shot from next month.

Read More

Top Glove Bets On Pandemic Boom To Propel Ambitious $1.9 Billion HK Listing

Top Glove's sales benefited greatly from the COVID-19 pandemic but the company also suffered an outbreak causing 5,000 infections, one death and rebuke from investors including BlackRock Inc.

Read More

UK To Receive 10 Million Astrazeneca COVID-19 Vaccine Doses From India's Serum Institute

The UK government said the agreement follows assurances from the SII that providing doses to the UK would not impact its commitment to provide vaccines to poorer countries

Read More

Biocon Biologics Appoints Susheel Umesh As Chief Commercial Officer For Emerging Markets

Biocon Biologics is into developing biosimilars that expand patient access to a cutting-edge class of therapies across the world.

Read More

J&J Waiting On New Plant Approval To Ship High Volumes Of Vaccine: Executive

J&J is also working to expand its manufacturing capacity globally and is in talks with potential new partners, Stoffels said, adding that he expects to be able to announce more manufacturing deals soon.

Read More

Biocon Biologics Elevates Shreehas Tambe As Deputy Chief Executive Officer

Prior to being appointed as deputy chief executive officer, Tambe was the chief operating officer and a key member of the executive leadership team at the company.

Read More

AstraZeneca Has Sold Its Stake In Moderna For More Than $1 Billion

AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic

Read More

Physical activity in youth with autism can be boosted by picture books

Physical activity in youth with autism can be boosted by picture books

Read More

Movement for ataxia patients can be restored by deep brain stimulation and exercise

Movement for ataxia patients can be restored by deep brain stimulation and exercise

Read More

FDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs Up Expected

J&J's vaccine uses a common cold virus known as adenovirus type 26 to introduce coronavirus proteins into cells in the body and trigger an immune response.

Read More

Pfizer COVID-19 Vaccine Reduces Transmission After One Dose - UK Study

Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.

Read More

Malaysia's Top Glove Plans To Raise $1.9 Billion Through Hong Kong Listing

The Kuala Lumpur-listed company floated the idea to seek a listing on the Hong Kong stock exchange in September, after its profit soared more than 17-times for the quarter ended August last year.

Read More